mesoderm

(redirected from Paraxial mesoderm)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Paraxial mesoderm: notochord, Intermediate mesoderm, somitic mesoderm

mes·o·derm

 (mĕz′ə-dûrm′, mĕs′-)
n.
The middle embryonic germ layer, lying between the ectoderm and the endoderm, from which connective tissue, muscle, bone, and the urogenital and circulatory systems develop.

mes′o·der′mal, mes′o·der′mic adj.

mesoderm

(ˈmɛsəʊˌdɜːm)
n
(Zoology) the middle germ layer of an animal embryo, giving rise to muscle, blood, bone, connective tissue, etc. See also ectoderm, endoderm
ˌmesoˈdermal, ˌmesoˈdermic adj

mes•o•derm

(ˈmɛz əˌdɜrm, ˈmɛs-, ˈmi zə-, -sə-)

n.
the middle embryonic germ layer, between the ectoderm and endoderm, from which connective tissue, muscles, and blood vessels develop.
[1870–75]
mes`o•der′mal, mes`o•der′mic, adj.

mesoderm

An embryo’s middle germ layer, which develops into the bones and muscles. See ectoderm, endoderm.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.mesoderm - the middle germ layer that develops into muscle and bone and cartilage and blood and connective tissuemesoderm - the middle germ layer that develops into muscle and bone and cartilage and blood and connective tissue
germ layer - (embryology) any of the 3 layers of cells differentiated in embryos following gastrulation
chordamesoderm, chordomesoderm - the area of mesoderm that forms the notochord
mesenchyme - mesodermal tissue that forms connective tissue and blood and smooth muscles
Translations

mes·o·derm

n. mesodermo, capa media germinativa del embrión situada entre el ectodermo y endodermo de la cual provienen el tejido óseo, el muscular, los vasos sanguíneos y linfáticos, y las membranas del corazón y abdomen.
References in periodicals archive ?
BASEL, Switzerland, June 8, 2016--CRISPR Therapeutics and French company Anagenesis Biotechnologies (Illkirch) announced a strategic inlicensing and collaboration agreement that grants CRISPR a license to Anagenesis' proprietary Paraxial Mesoderm Multipotent Cells (P2MCs) technology for cell therapy for all human muscle diseases.
BASEL, Switzerland, June 8, 2016 -- CRISPR Therapeutics and French company Anagenesis Biotechnologies (Illkirch) announced a strategic inlicensing and collaboration agreement that grants CRISPR a license to Anagenesis' proprietary Paraxial Mesoderm Multipotent Cells (P2MCs) technology for cell therapy for all human muscle diseases.
Somites are formed from paraxial mesoderm that lies on each side of the neural tube.